ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. An enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests.
ARUP’s comprehensive clinical and anatomic pathology test menu includes the areas of allergy and immunology, chemistry, cytogenetics, endocrinology, fetal risk assessment, genetics, hematology, hepatitis and HIV, infectious diseases, neurology, oncology, and pathology. ARUP performs 99 percent of all testing on-site, operating 24 hours per day, seven days a week, and processing more than 30,000–35,000 specimens of blood, body fluid, and tissue biopsies per day.
ARUP provides some of the best turnaround times available in the industry, due in part to the advanced instrumentation and automated systems used in specimen receiving, tracking, and retrieving. Test results are also rapidly delivered to clients through customized information systems.
- Erickson JA, Grenache DG. A chromogranin A ELISA absent of an apparent high-dose hook effect observed in other chromogranin A immunoassays. Clinica Chimica Acta 2016;452:120-123.
- Sono-Koree NK, Crist RA, Frank EL, Rodgers GM, Smock KJ. A High-Performance Liquid Chromatography Method for the Serotonin Release Assay is Equivalent to the Radioactive Method. International Journal of Laboratory Hematology 2016;38(1):72-80.
- Akbas N, Gonzalez G, Buffone GJ, Grenache DG, Devaraj S. A Library of Rare β1-Antitrypsin (AAT) Variant Phenotypes to Aid in the Diagnosis of AAT Deficiency. American Journal of Clinical Pathology 2016;146(3):289-93.
- Yuzyuk T, Liu A, Thomas A, Wilson JE, De Biase I, Longo N, Pasquali M. A novel method for simultaneous quantification of alpha-Aminoadipic semialdehyde/Piperideine-6-carboxylate and Pipecolic acid in plasma and urine. Journal of Chromatography B 2016;1017-1018:145-52.
- Tantravahi SK, Szankasi P, Khorashad JS, Dao KH, Kovacsovics T, Kelley TW, Deininger MW. A phase II study of the efficacy and determinants of response to 5-azacitidine (Vidaza) in patients with chronic myelomonocytic leukemia. Leukemia & Lymphoma 2016;57(10):2441-4.
- Johnson-Davis KL, Sadler AJ, Genzen JR. A retrospective analysis of urine drugs of abuse immunoassay positivity rates at a national reference laboratory. Journal of Analytical Toxicology 2016;40(2):97-107.
- Hobert JA, Liu A, Pasquali M. Acylglycine Analysis by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS). Current Protocols in Human Genetics 2016;91:17.25.1-17.25.
- Mason CC, Khorashad JS, Tantravahi SK, Kelley TW, Zabriskie MS, Yan D, Pomicter AD, Reynolds KR, Eiring AM, Kronenberg Z, Sherman RL, Tyner JW, Dalley BK, Dao KH, Yandell M, Druker BJ, Gotlib J, O'Hare T, Deininger MW. Age-related mutations and chronic myelomonocytic leukemia. Leukemia 2016;30(4):906-13.
- Zantek ND, Hayward CP, Simcox TG, Smock KJ, Hsu P, Van Cott EM. An assessment of the state of current practice in specialized coagulation laboratories. American Journal of Clinical Pathology 2016;146(3):378-83.
- Goker-Alpan O, Longo N, McDonald M, Shankar SP, Schiffmann R, Chang P, Shen Y, Pano A. An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy. Drug Design, Development and Theory 2016;10:1771-81.